Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
2-15-1|BPm-mg 0.003,10/78|1| 92|benzopyrene|0.003|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-1-1|1|316|Other deterministic changes|Lower respiratory system|n/a|
2-15-1|BPm-mg 0.003,10/78|1| 92|benzopyrene|0.003|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-1-2|1|764|Other deterministic changes|Lower respiratory system|n/a|
2-15-1|BPm-mg 0.003,10/78|1| 92|benzopyrene|0.003|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study 
|2-15-1-3|1|852|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-15-1|BPm-mg 0.003,10/78|1| 92|benzopyrene|0.003|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-1-4|1|912|Other deterministic changes|Lower respiratory system|n/a|
2-15-1|BPm-mg 0.003,10/78|1| 92|benzopyrene|0.003|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-1-5|1|925|Other deterministic changes|Lower respiratory system|n/a|
2-15-2|BPm-mg 0.01,10/78|1| 92|benzopyrene|0.01|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-2-1|2|652|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-15-2|BPm-mg 0.01,10/78|1| 92|benzopyrene|0.01|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-2-2|2|652|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-2|BPm-mg 0.01,10/78|1| 92|benzopyrene|0.01|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-2-3|2|827|Other deterministic changes|Lower respiratory system|n/a|
2-15-2|BPm-mg 0.01,10/78|1| 92|benzopyrene|0.01|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-2-4|2|975|Other deterministic changes|Lower respiratory system|n/a|
2-15-2|BPm-mg 0.01,10/78|1| 92|benzopyrene|0.01|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-2-5|2|986|Other deterministic changes|Lower respiratory system|n/a|
2-15-3|BPmf-mg 0.03,10/78|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-3-1|3|17|Other deterministic changes|Lower respiratory system|n/a|
2-15-3|BPmf-mg 0.03,10/78|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-3-2|3|40|Other deterministic changes|Lower respiratory system|n/a|
2-15-3|BPmf-mg 0.03,10/78|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-3-3|3|380|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-15-3|BPmf-mg 0.03,10/78|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-3-4|3|530|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-15-3|BPmf-mg 0.03,10/78|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-3-5|3|836|Other deterministic changes|Lower respiratory system|n/a|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-1|4|312|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-2|4|312|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-3|4|322|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-4|4|322|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-5|4|352|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-6|4|358|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-7|4|393|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-8|4|511|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-9|4|527|Other deterministic changes|Lower respiratory system|n/a|
2-15-4|BPmm-mg 0.03,1/81|1| 92|benzopyrene|0.03|milligrams|Injection, intramuscular| IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-15-4-10|4|599|Other deterministic changes|Lower respiratory system|n/a|
2-15-5|BPm-mg 0.1,10/78|1| 92|benzopyrene|0.1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-5-1|5|248|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-5|BPm-mg 0.1,10/78|1| 92|benzopyrene|0.1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-5-2|5|248|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-5|BPm-mg 0.1,10/78|1| 92|benzopyrene|0.1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-5-3|5|298|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-5|BPm-mg 0.1,10/78|1| 92|benzopyrene|0.1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-5-4|5|318|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-15-5|BPm-mg 0.1,10/78|1| 92|benzopyrene|0.1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-5-5|5|366|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-6|BPm-mg 0.3,10/78|1| 92|benzopyrene|0.3|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-6-1|6|204|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-15-6|BPm-mg 0.3,10/78|1| 92|benzopyrene|0.3|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-6-2|6|218|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-15-6|BPm-mg 0.3,10/78|1| 92|benzopyrene|0.3|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-6-3|6|241|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-6|BPm-mg 0.3,10/78|1| 92|benzopyrene|0.3|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-6-4|6|241|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-6|BPm-mg 0.3,10/78|1| 92|benzopyrene|0.3|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-6-5|6|257|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-15-7|BPt-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-7-1|7|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-7|BPt-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-7-2|7|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-7|BPt-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-7-3|7|273|Hyperplastic changes|Lower respiratory system|n/a|
2-15-7|BPt-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-7-4|7|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-7|BPt-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intramuscular| IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-7-5|7|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-8|BPt-BN-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-8-1|8|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-8|BPt-BN-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-8-2|8|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-8|BPt-BN-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-8-3|8|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-8|BPt-BN-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-8-4|8|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-8|BPt-BN-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-8-5|8|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-9|BPt-BN*-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-1|9|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-9|BPt-BN*-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-2|9|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-9|BPt-BN*-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-3|9|273|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-9|BPt-BN*-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-4|9|273|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-9|BPt-BN*-mg 1,2/82|1| 92|benzopyrene|1|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-5|9|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-9|BPt-BN*-mg 1,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 12 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-1|9|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-9|BPt-BN*-mg 1,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 12 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-2|9|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-9|BPt-BN*-mg 1,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 12 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-3|9|273|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-9|BPt-BN*-mg 1,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 12 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-4|9|273|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-9|BPt-BN*-mg 1,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 12 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-9-5|9|273|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-1|10|207|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-2|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-3|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-4|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-5|10|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-10|BPt-BN-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-6|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-1|10|207|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-2|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-3|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-4|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-10|BPt-BN-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-5|10|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-10|BPt-BN-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-10-6|10|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-1|11|215|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-2|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-3|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-4|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-5|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|1| 92|benzopyrene|3|milligrams|Injection, intratracheal| Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-6|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-1|11|215|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-2|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-3|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-4|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-5|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-11|BPt-BN*-mg 3,2/82|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-11-6|11|223|Other deterministic changes|Lower respiratory system|n/a|
2-15-12|BPt-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-12-1|12|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-12|BPt-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-12-2|12|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-12|BPt-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-12-3|12|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-12|BPt-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-12-4|12|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-12|BPt-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-12-5|12|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-1|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-2|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-3|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-4|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-5|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 2 IM inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-1|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 2 IM inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-2|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 2 IM inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-3|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 2 IM inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-4|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-13|BPt-BN-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 2 IM inject. 15 d interval|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-13-5|13|212|Other deterministic changes|Lower respiratory system|n/a|
2-15-14|BPt-BN*-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-1|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-2|14|212|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-14|BPt-BN*-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-3|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-4|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|1| 92|benzopyrene|5|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-5|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-1|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-2|14|212|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-14|BPt-BN*-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-3|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-4|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-14|BPt-BN*-mg 5,2/82|2| 110|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-14-5|14|212|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-1|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-2|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-3|15|76|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-4|15|76|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-5|15|76|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-6|15|76|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-7|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-8|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-1|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-2|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-3|15|76|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-4|15|76|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-5|15|76|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-6|15|76|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-7|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-15|CR-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-15-8|15|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-1|16|89|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-2|16|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-3|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-4|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-5|16|226|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-6|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-7|16|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-16|CR-BN*-mg 5,10/83|1| 92|crocidolite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-8|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-1|16|89|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-2|16|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-3|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-4|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-5|16|226|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-6|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-7|16|226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-16|CR-BN*-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-16-8|16|226|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-1|17|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-2|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-3|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-4|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-5|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-6|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-7|17|210|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-8|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-9|17|210|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-10|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-11|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-1|17|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-2|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-3|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-4|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-5|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-6|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-7|17|210|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-8|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-9|17|210|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-10|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-17|CR-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-17-11|17|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-1|18|227|Other deterministic changes|Lower respiratory system|n/a|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-2|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-3|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-4|18|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-5|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-6|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-7|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-8|18|231|Other deterministic changes|Lower respiratory system|n/a|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-9|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-10|18|231|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-18|CR-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-11|18|231|Other deterministic changes|Lower respiratory system|n/a|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-1|18|227|Other deterministic changes|Lower respiratory system|n/a|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-2|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-3|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-4|18|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-5|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-6|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-7|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-8|18|231|Other deterministic changes|Lower respiratory system|n/a|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-9|18|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-10|18|231|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-18|CR-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-18-11|18|231|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-1|19|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-2|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-3|19|211|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-4|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-5|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-6|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-7|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-8|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-9|19|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-10|19|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-19|CRl-BN-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-11|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-1|19|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-2|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-3|19|211|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-4|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-5|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-6|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-7|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-8|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-9|19|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-10|19|211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-19|CRl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-19-11|19|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-1|20|210|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-2|20|211|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-3|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-4|20|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-5|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-6|20|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-7|20|230|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-8|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-9|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-10|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-11|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-20|CRl-BN*-mg 10,10/83|1| 92|crocidolite|10|milligrams|Injection, intratracheal| Crocidolite lixif.Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-12|20|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-1|20|210|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-2|20|211|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-3|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-4|20|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-5|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-6|20|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-7|20|230|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-8|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-9|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-10|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-11|20|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-20|CRl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-20-12|20|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-1|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-2|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-3|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-4|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-5|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-1|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-2|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-3|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-4|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-21|CH-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-21-5|21|79|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-1|22|206|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-2|22|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-3|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-4|22|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-5|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-6|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-7|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-8|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-9|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-10|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-11|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-12|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-13|22|225|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-1|22|206|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-2|22|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-3|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-4|22|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-5|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-6|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-7|22|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-8|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-9|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-10|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-11|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-12|22|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-22|CHl-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-22-13|22|225|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-1|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-2|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-3|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-4|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-5|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-6|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-7|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-1|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-2|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-3|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-4|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-5|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-6|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-23|CHl-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-23-7|23|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-1|24|217|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-2|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-3|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-4|24|230|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-5|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-6|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-7|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile lixif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-8|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-1|24|217|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-2|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-3|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-4|24|230|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-5|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-6|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-7|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-24|CHs-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-24-8|24|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-1|25|200|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-2|25|217|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-3|25|224|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-4|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-5|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-6|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-7|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|1| 92|chrysotyl|10|milligrams|Injection, intratracheal| Chrysotile sonif. Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-8|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-1|25|200|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-2|25|217|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-3|25|224|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-4|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-5|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-6|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-7|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-25|CH-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-25-8|25|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-1|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-2|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-3|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-4|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-5|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-6|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-7|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-8|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-1|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-2|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-3|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-4|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-5|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-6|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-7|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-26|CH-BN*-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-26-8|26|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-1|27|198|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-2|27|202|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-3|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-4|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-5|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-6|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-7|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-8|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|1| 92|chrysotyl|20|milligrams|Injection, intratracheal| Intratracheal|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-9|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-1|27|198|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-2|27|202|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-3|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-4|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-5|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-6|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-7|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-8|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-27|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-27-9|27|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-1|28|210|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-2|28|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-3|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-4|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-5|28|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-6|28|225|Hyperplastic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-7|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|1| 92|hematite|5|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-8|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-1|28|210|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-2|28|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-3|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-4|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-5|28|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-6|28|225|Hyperplastic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-7|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-28|HE-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-28-8|28|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-1|29|76|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-2|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-3|29|76|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-4|29|76|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-5|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-6|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-7|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-8|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-1|29|76|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-2|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-3|29|76|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-4|29|76|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-5|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-6|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-7|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-29|HE-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-29-8|29|76|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-1|30|86|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-2|30|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-3|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-4|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-5|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-6|30|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-30|HE-BN*-mg 10,10/83|1| 92|hematite|10|milligrams|Injection, intratracheal| Intratracheal|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-7|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-1|30|86|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-2|30|210|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-3|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-4|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-5|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-6|30|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-30|HE-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-30-7|30|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-1|31|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-2|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-3|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-4|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-5|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-6|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-7|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-8|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-9|31|225|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-10|31|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-11|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|1| 92|hematite|15|milligrams|Injection, intratracheal| Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-12|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-1|31|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-2|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-3|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-4|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-5|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-6|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-7|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-8|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-9|31|225|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-10|31|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-11|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-31|HE-BN-mg 15,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-31-12|31|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-1|32|78|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-2|32|78|Hyperplastic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-3|32|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-4|32|78|Neoplasia benign|Lower respiratory system,MA: 0000415 - lung|,MPATH: 240 - hemangioma|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-5|32|78|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-6|32|78|Hyperplastic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-7|32|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-8|32|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-1|32|78|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-2|32|78|Hyperplastic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-3|32|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-4|32|78|Neoplasia benign|Lower respiratory system,MA: 0000415 - lung|,MPATH: 240 - hemangioma|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-5|32|78|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-6|32|78|Hyperplastic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-7|32|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-32|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-32-8|32|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-1|33|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-2|33|224|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-3|33|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-4|33|225|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-5|33|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-6|33|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-7|33|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-33|QU-BN-mg 5,10/83|1| 92|quartz|5|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-8|33|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-1|33|224|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-2|33|224|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-3|33|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-4|33|225|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-5|33|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-6|33|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-7|33|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-33|QU-BN-mg 5,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-33-8|33|225|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-1|34|77|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-2|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-3|34|77|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-4|34|77|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| metastatic,MPATH: 409 - fibrous histiocytoma|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-5|34|77|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-6|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-7|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-8|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-1|34|77|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-2|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-3|34|77|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-4|34|77|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| metastatic,MPATH: 409 - fibrous histiocytoma|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-5|34|77|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-6|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-7|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-34|QU-BN-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-34-8|34|77|Other deterministic changes|Lower respiratory system|n/a|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-1|35|200|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-2|35|214|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-3|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-4|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-5|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-6|35|225|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-7|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|1| 92|quartz|10|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-8|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-1|35|200|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-2|35|214|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-3|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-4|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-5|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-6|35|225|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-7|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-35|QU-BN*-mg 10,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-35-8|35|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-1|36|75|Other deterministic changes|Lower respiratory system|n/a|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-2|36|82|Other deterministic changes|Lower respiratory system|n/a|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-3|36|89|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-4|36|196|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-5|36|196|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-6|36|196|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-7|36|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-8|36|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-9|36|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-10|36|209|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-11|36|209|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|1| 92|quartz|20|milligrams|Injection, intratracheal| Quartz DQ 12 Intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-12|36|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-1|36|75|Other deterministic changes|Lower respiratory system|n/a|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-2|36|82|Other deterministic changes|Lower respiratory system|n/a|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-3|36|89|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-4|36|196|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-5|36|196|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-6|36|196|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-7|36|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-8|36|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-9|36|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-10|36|209|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-11|36|209|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-36|QU-BN-mg 20,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-36-12|36|209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-15-37|BE-BN4-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| dust Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-1|37|88|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| dust Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-2|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| dust Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-3|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| dust Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-4|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| dust Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-5|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| dust Intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-6|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-1|37|88|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-2|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-3|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-4|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-5|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-37|BE-BN4-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 4 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-37-6|37|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| Intratracheadust l|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-1|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| Intratracheadust l|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-2|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| Intratracheadust l|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-3|38|257|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-38|BE-BN8-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| Intratracheadust l|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-4|38|257|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-38|BE-BN8-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| Intratracheadust l|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-5|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|1| 92|beryllium|0.6|milligrams|Injection, intratracheal| Intratracheadust l|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-6|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-1|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-2|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-3|38|257|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-38|BE-BN8-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-4|38|257|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-38|BE-BN8-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-5|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-38|BE-BN8-mg 0.6,10/83|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| 8 IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-38-6|38|257|Other deterministic changes|Lower respiratory system|n/a|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-1|39|445|Other deterministic changes|Lower respiratory system|n/a|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-2|39|447|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-3|39|482|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-4|39|483|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-5|39|486|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-6|39|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-7|39|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-8|39|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-9|39|494|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-10|39|496|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-11|39|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-12|39|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-13|39|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-14|39|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-15|39|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-16|39|513|Other deterministic changes|Lower respiratory system|n/a|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-17|39|541|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-18|39|548|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-19|39|555|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-20|39|578|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-21|39|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-22|39|604|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-23|39|605|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-24|39|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-25|39|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-26|39|637|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-27|39|660|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-28|39|670|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-29|39|705|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-30|39|730|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-31|39|732|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-39|SA-mg 0,6/77|1| 92|saline control||unit code not relevant|Injection intrapleural| intrapleural|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-39-32|39|734|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-1|40|86|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-2|40|86|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-3|40|207|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-4|40|221|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-5|40|259|Neoplasia unclassified|Reproductive system,MA: 0002420 - gonad|,MPATH: 322 - teratoma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-6|40|303|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-7|40|303|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-8|40|371|Other deterministic changes|Lower respiratory system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-9|40|410|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-10|40|440|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-11|40|466|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-12|40|466|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-13|40|475|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-14|40|483|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-15|40|483|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-16|40|485|Neoplasia systemic|Haematolymphatic system|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-17|40|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-18|40|494|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-19|40|497|Other deterministic changes|Whole body|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-20|40|497|Other deterministic changes|Whole body|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-21|40|497|Other deterministic changes|Whole body|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-22|40|497|Other deterministic changes|Whole body|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-23|40|497|Other deterministic changes|Whole body|n/a|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-24|40|498|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-25|40|499|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-26|40|501|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-27|40|508|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-28|40|508|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-29|40|509|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-30|40|514|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-31|40|522|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-32|40|525|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-33|40|533|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-34|40|543|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-35|40|554|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-36|40|558|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-37|40|560|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-38|40|562|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-39|40|569|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-40|40|572|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-41|40|580|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-42|40|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-43|40|584|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-44|40|585|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-45|40|590|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-46|40|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-47|40|602|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-48|40|633|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-49|40|651|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-50|40|653|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-51|40|704|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-40|CR,6/77|1| 92|crocidolite||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-40-52|40|729|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-41|CR+CH,2/78|1| 92|crocidolite||unit code not relevant|Injection intrapleural| Crocidolite+Chrysotile|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-41-1|41|263|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000003 - organ system|,MPATH: 397 - osteosarcoma|
2-15-41|CR+CH,2/78|1| 92|crocidolite||unit code not relevant|Injection intrapleural| Crocidolite+Chrysotile|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-41-2|41|409|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-41|CR+CH,2/78|1| 92|crocidolite||unit code not relevant|Injection intrapleural| Crocidolite+Chrysotile|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-41-3|41|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-41|CR+CH,2/78|1| 92|crocidolite||unit code not relevant|Injection intrapleural| Crocidolite+Chrysotile|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-41-4|41|445|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-41|CR+CH,2/78|1| 92|crocidolite||unit code not relevant|Injection intrapleural| Crocidolite+Chrysotile|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-41-5|41|463|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-1|42|8|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-2|42|8|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-3|42|37|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-4|42|90|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-5|42|90|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-6|42|227|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-7|42|308|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-8|42|308|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-9|42|370|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-10|42|377|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-11|42|404|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-12|42|408|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-13|42|411|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-14|42|428|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-15|42|447|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-16|42|450|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-17|42|472|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-18|42|473|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-19|42|476|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-20|42|476|Other deterministic changes|Lower respiratory system|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-21|42|481|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-22|42|481|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-23|42|484|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-24|42|486|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-25|42|486|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-26|42|486|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-27|42|487|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-28|42|489|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-29|42|490|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-30|42|491|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-31|42|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-32|42|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-33|42|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-34|42|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-35|42|494|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-36|42|495|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-37|42|496|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-38|42|496|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-39|42|496|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-40|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-41|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-42|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-43|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-44|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-45|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-46|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-47|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-48|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-49|42|499|Other deterministic changes|Whole body|n/a|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-50|42|569|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-51|42|589|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-42|CRnl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| non-lixified|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-42-52|42|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-1|43|377|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-2|43|381|Other deterministic changes|Lower respiratory system|n/a|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-3|43|388|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-4|43|448|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-5|43|469|Other deterministic changes|Lower respiratory system|n/a|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-6|43|475|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-7|43|477|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-8|43|478|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-9|43|485|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-10|43|486|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-11|43|490|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-12|43|490|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-13|43|491|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-14|43|493|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-15|43|494|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-16|43|495|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-17|43|498|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-18|43|498|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-19|43|498|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-20|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-21|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-22|43|499|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-23|43|499|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-24|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 408 - soft tissue fibrosarcoma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-25|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-26|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-27|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-28|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-29|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-30|43|499|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-31|43|499|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-43|CRl-OX20,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 20% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-43-32|43|499|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-1|44|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-2|44|78|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-3|44|277|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-4|44|306|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-5|44|306|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-6|44|321|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-7|44|375|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-8|44|434|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-9|44|474|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-10|44|474|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-11|44|485|Other deterministic changes|Lower respiratory system|n/a|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-12|44|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-13|44|488|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-14|44|496|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-15|44|500|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-16|44|501|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-17|44|502|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-18|44|503|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-19|44|505|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-20|44|506|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-21|44|510|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-22|44|518|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-23|44|535|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-24|44|547|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-25|44|547|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-26|44|550|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-27|44|550|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-28|44|558|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-29|44|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-30|44|568|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-31|44|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-32|44|587|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-33|44|589|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-34|44|607|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-35|44|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-36|44|618|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-37|44|618|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-38|44|623|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-39|44|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-40|44|633|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-41|44|634|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-42|44|635|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-43|44|637|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-44|44|637|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-45|44|637|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-46|44|670|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-47|44|670|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-44|CRl-OX50,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 50% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-44-48|44|671|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-1|45|459|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-2|45|460|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-3|45|461|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-4|45|462|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-5|45|472|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-6|45|473|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-7|45|475|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-8|45|480|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-9|45|482|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-10|45|483|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-11|45|485|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-12|45|505|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-13|45|517|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-14|45|517|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-15|45|521|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-16|45|521|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-17|45|529|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-18|45|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-19|45|567|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-20|45|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-21|45|571|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-22|45|592|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-23|45|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-24|45|623|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 551 - sarcoma|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-25|45|636|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-26|45|640|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-27|45|641|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-28|45|656|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-29|45|708|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-30|45|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-31|45|721|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-45|CRl-OX70,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified  70% Oxal.Ac.|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-45-32|45|734|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-1|46|90|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-2|46|90|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-3|46|229|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-4|46|297|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-5|46|297|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-6|46|299|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-7|46|354|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-8|46|375|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-9|46|448|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-10|46|467|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-11|46|472|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-12|46|474|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-13|46|474|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-14|46|475|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-15|46|477|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-16|46|484|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-17|46|494|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-18|46|495|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-19|46|495|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-20|46|501|Other deterministic changes|Whole body|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-21|46|501|Other deterministic changes|Whole body|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-22|46|501|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-23|46|501|Other deterministic changes|Whole body|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-24|46|501|Other deterministic changes|Whole body|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-25|46|508|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-26|46|508|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-27|46|512|Other deterministic changes|Lower respiratory system|n/a|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-28|46|518|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-29|46|529|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-30|46|533|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-31|46|535|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-32|46|573|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-33|46|575|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-34|46|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-35|46|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-36|46|587|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-37|46|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-38|46|595|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-39|46|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-40|46|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-41|46|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-42|46|650|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-43|46|677|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-44|46|685|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-45|46|705|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-46|46|708|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-47|46|729|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-46|CRl-OX100,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% Oxal.Ac.|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-46-48|46|734|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-1|47|410|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-2|47|481|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-3|47|490|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-4|47|491|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-5|47|503|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-6|47|520|Other deterministic changes|Whole body|n/a|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-7|47|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-8|47|546|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-9|47|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-10|47|574|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-11|47|655|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-12|47|685|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-13|47|742|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-14|47|742|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-15|47|744|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-47|CRl-OX100HCl,6/77|1| 92|chrysotyl||unit code not relevant|Injection intrapleural| lixified 100% H Cl.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-47-16|47|744|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-1|48|86|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-2|48|86|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-3|48|209|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-4|48|221|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-5|48|303|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-6|48|303|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-7|48|371|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-8|48|397|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-9|48|471|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-10|48|471|Other deterministic changes|Lower respiratory system|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-11|48|490|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-12|48|506|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-13|48|506|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-14|48|506|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-15|48|511|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-16|48|511|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-17|48|532|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-18|48|533|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-19|48|534|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-20|48|535|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-21|48|536|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-22|48|547|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-23|48|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-24|48|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-25|48|566|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-26|48|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-27|48|568|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-28|48|584|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-29|48|585|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-30|48|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-31|48|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-32|48|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-33|48|621|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-34|48|625|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-35|48|633|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-36|48|634|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-37|48|637|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-38|48|646|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-39|48|647|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-40|48|658|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-41|48|661|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-42|48|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-43|48|694|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-44|48|704|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-45|48|723|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-46|48|723|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-47|48|729|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-48|48|729|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-49|48|735|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-50|48|758|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-51|48|784|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-15-48|GL,6/77|1| 92|glas fibers||unit code not relevant|Injection intrapleural| intrapleural|52 (52 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-15-48-52|48|786|Other deterministic changes|Lower respiratory system|n/a|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-1|49|205|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-2|49|218|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-3|49|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-4|49|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-5|49|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-6|49|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-7|49|233|Hyperplastic changes|Lower respiratory system|n/a|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-8|49|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-9|49|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-10|49|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-11|49|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-49|PbCr-mg 20,2/84|1| 92|Pb chromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-49-12|49|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-1|50|221|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-2|50|222|Other deterministic changes|Lower respiratory system|n/a|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-3|50|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-4|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-5|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-6|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-7|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-8|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-9|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-10|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-11|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-50|PbSCr-mg 20,2/84|1| 92|Pb sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-50-12|50|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-51|MoSCr-mg 20,2/84|1| 92|Mo sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-51-1|51|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-51|MoSCr-mg 20,2/84|1| 92|Mo sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-51-2|51|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-51|MoSCr-mg 20,2/84|1| 92|Mo sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-51-3|51|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-51|MoSCr-mg 20,2/84|1| 92|Mo sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-51-4|51|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-51|MoSCr-mg 20,2/84|1| 92|Mo sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-51-5|51|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-51|MoSCr-mg 20,2/84|1| 92|Mo sulfochromate|20|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-51-6|51|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-52|KCr-mg 5,2/84|1| 92|K bichromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-52-1|52|218|Other deterministic changes|Lower respiratory system|n/a|
2-15-52|KCr-mg 5,2/84|1| 92|K bichromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-52-2|52|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-52|KCr-mg 5,2/84|1| 92|K bichromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-52-3|52|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-52|KCr-mg 5,2/84|1| 92|K bichromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-52-4|52|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-52|KCr-mg 5,2/84|1| 92|K bichromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-52-5|52|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-52|KCr-mg 5,2/84|1| 92|K bichromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-52-6|52|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-53|ZnCr-mg 5,2/84|1| 92|Zn chromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-53-1|53|218|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-53|ZnCr-mg 5,2/84|1| 92|Zn chromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-53-2|53|220|Other deterministic changes|Lower respiratory system|n/a|
2-15-53|ZnCr-mg 5,2/84|1| 92|Zn chromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-53-3|53|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-53|ZnCr-mg 5,2/84|1| 92|Zn chromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-53-4|53|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-53|ZnCr-mg 5,2/84|1| 92|Zn chromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-53-5|53|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-53|ZnCr-mg 5,2/84|1| 92|Zn chromate|5|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-53-6|53|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-1|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-2|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-3|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-4|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-5|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| intratracheal some animals 20 mg|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-6|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-1|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-2|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-3|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-4|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-5|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-54|ZnCrBN-mg 10,2/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-54-6|54|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| Zinc chromate tetraoxyl|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-1|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| Zinc chromate tetraoxyl|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-2|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| Zinc chromate tetraoxyl|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-3|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| Zinc chromate tetraoxyl|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-4|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| Zinc chromate tetraoxyl|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-5|55|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-55|ZnCrOBN-mg 10,4/85|1| 92|Zn chromate|10|milligrams|Injection, intratracheal| Zinc chromate tetraoxyl|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-6|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-1|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-2|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-3|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-4|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-55|ZnCrOBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-5|55|233|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-55|ZnCrOBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-55-6|55|233|Other deterministic changes|Lower respiratory system|n/a|
2-15-56|SrCr-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-56-1|56|71|Other deterministic changes|Lower respiratory system|n/a|
2-15-56|SrCr-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-56-2|56|71|Other deterministic changes|Lower respiratory system|n/a|
2-15-56|SrCr-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-56-3|56|71|Other deterministic changes|Lower respiratory system|n/a|
2-15-56|SrCr-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-56-4|56|7709|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-1|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-2|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-3|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-4|57|232|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-57|SrCrBN-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-5|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|1| 92|Sr chromate|10|milligrams|Injection, intratracheal| intratracheal|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-6|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-1|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-2|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-3|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-4|57|232|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-15-57|SrCrBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-5|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-57|SrCrBN-mg 10,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-57-6|57|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-1|58|204|Hyperplastic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-2|58|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-3|58|224|Other deterministic changes|Whole body|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-4|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-5|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-6|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-7|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-8|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-9|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-10|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-11|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-12|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|1| 92|Sr chromate|20|milligrams|Injection, intratracheal| intratracheal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-13|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-1|58|204|Hyperplastic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-2|58|211|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-3|58|224|Other deterministic changes|Whole body|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-4|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-5|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-6|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-7|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-8|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-9|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-10|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-11|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-12|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-58|SrCrBN-mg 20,4/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-58-13|58|232|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-1|59|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-2|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-3|59|235|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-4|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-5|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-6|59|235|Hyperplastic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-7|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-8|59|235|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-9|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-10|59|235|Hyperplastic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-11|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|1| 92|Ni La dust|75|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-12|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-1|59|230|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-2|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-3|59|235|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-4|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-5|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-6|59|235|Hyperplastic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-7|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-8|59|235|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-9|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-10|59|235|Hyperplastic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-11|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-59|NiLaBN-mg 75,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-59-12|59|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-1|60|229|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-2|60|235|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-3|60|235|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-4|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-5|60|235|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-6|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-7|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-8|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-9|60|235|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-10|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-11|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|1| 92|Ni La dust|150|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-12|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-1|60|229|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-2|60|235|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-3|60|235|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-4|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-5|60|235|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-6|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-7|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-8|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-9|60|235|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-10|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-11|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-60|NiLaBn-mg 150,5/84|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-60-12|60|235|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-1|61|6|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-2|61|6|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-3|61|227|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-4|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-5|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-6|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-7|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-8|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-9|61|244|Hyperplastic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-10|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-11|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|1| 92|Ni sulfide|1|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-12|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-1|61|6|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-2|61|6|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-3|61|227|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-4|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-5|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-6|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-7|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-8|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-9|61|244|Hyperplastic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-10|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-11|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-61|NiSBN-mg 1,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-61-12|61|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-1|62|6|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-2|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-3|62|244|Hyperplastic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-4|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-5|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-6|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-7|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-8|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-9|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-10|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-11|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|1| 92|Ni sulfide|3|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-12|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-1|62|6|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-2|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-3|62|244|Hyperplastic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-4|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-5|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-6|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-7|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-8|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-9|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-10|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-11|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-62|NiSBN-mg 5,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-62-12|62|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-1|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-2|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-3|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-4|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-5|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-6|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-7|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-8|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-9|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-10|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-11|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|1| 92|Ni sulfide|10|milligrams|Injection, intratracheal| intratracheal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-12|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-1|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-2|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-3|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-4|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-5|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-6|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-7|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-8|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-9|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-10|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-11|63|244|Other deterministic changes|Lower respiratory system|n/a|
2-15-63|NiSBN-mg 10,12/85|2| 122|BNF ß-naphtoflavone|25|milligrams|Injection, intramuscular| IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-15-63-12|63|244|Other deterministic changes|Lower respiratory system|n/a|
		
